amoxicillin 500mg and metronidazole 400mg
Combination Productmetronidazole 400mg and amoxicillin 500mg three times daily for two weeks
Other names: Amoxil and Flagyl
NCT Number: NCT03783845
Is the non-surgical periodontal therapy can improve glycemic control in type 2 diabetic patients with chronic periodontitis?
Looking for future studies?
Notify Me40 year–70 year
All sexes
Interventional
Phase 4
The aim of the present study was to monitor the clinical outcomes and the metabolic response of non-surgical periodontal therapy in patients with chronic periodontitis and uncontrolled type 2 diabetes.
Regarding clinical and metabolic parameters at baseline, no differences were displayed between two groups. However, at 3-months follow-up period the patients within a test group were demonstrated better clinical outcomes than patients in a control group
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Diagnosis of diabetes type 2 for more than five years Type 2 diabetes with HbA1c level from 7% to 9% at the last medical evaluation Diagnosis with chronic periodontitis
Exclusion criteria
Pregnancy
metronidazole 400mg and amoxicillin 500mg three times daily for two weeks
Other names: Amoxil and Flagyl
Time frame: 3 months
Blood was taken from a peripheral vein to monitor HbA1c using high-performance liquid chromatography
Taibah University
Other
The Effects of Non -Surgical Periodontal Therapy on Glycemic Control and Periodontal Health in Diabetic Patients With Periodontitis (Randomized Controlled Clinical Trial)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05823389
Chronic Disease, Chronic Periodontitis
Ramallah, Palestinian Territories
View Trial DetailsNCT04597073
Chronic Disease, Chronic Periodontitis
View Trial DetailsNCT06893107
Chronic Disease, Chronic Periodontitis
Fujairah, Emirate of Fujairah, United Arab Emirates
View Trial DetailsNCT04274244
Alveolar Bone Loss, Bone Diseases
Valencia, Spain
View Trial Details